We’re excited to share our latest project investigating the AKT1 oncogene and its role in the PI3K/AKT signaling pathway. By exploring AKT1 mutations, we aim to uncover new insights into cancer resistance mechanisms and potential therapeutic targets. This study is part of our commitment to advancing cancer research and developing innovative treatments.
Check out the enclosed diagram illustrating the key pathways and mechanisms involved! 🌐🧫